NASCOBAL
Total Payments
$498,750
Transactions
23,388
Doctors
7,113
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1,099 | 62 | 54 |
| 2023 | $6,746 | 387 | 247 |
| 2022 | $17,315 | 1,029 | 801 |
| 2021 | $50,721 | 3,212 | 1,815 |
| 2020 | $56,992 | 3,001 | 1,604 |
| 2019 | $125,633 | 4,024 | 2,311 |
| 2018 | $112,344 | 6,496 | 2,715 |
| 2017 | $127,901 | 5,177 | 2,301 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $376,402 | 23,290 | 75.5% |
| Consulting Fee | $101,015 | 27 | 20.3% |
| Travel and Lodging | $14,751 | 59 | 3.0% |
| Space rental or facility fees (teaching hospital only) | $6,500 | 6 | 1.3% |
| Education | $82.56 | 6 | 0.0% |
Top Doctors Receiving Payments for NASCOBAL — Page 285
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Internal Medicine | Milwaukee, WI | $10.63 | 1 |
| , M.D | Family Medicine | Huntsville, AL | $10.62 | 1 |
| , M.D | Surgery | Roslyn Heights, NY | $10.62 | 1 |
| , M.D., P.C | Gastroenterology | West Bloomfield, MI | $10.60 | 1 |
| , MD | Geriatric Medicine | Bedford, TX | $10.59 | 1 |
| , MD | Family Medicine | Oakland, NJ | $10.59 | 1 |
| , M.D | Pediatrics | Riverside, CA | $10.55 | 1 |
| , MD | Family Medicine | Pawleys Island, SC | $10.55 | 1 |
| , M.D | Internal Medicine | Birmingham, AL | $10.53 | 1 |
| , MD | Family Medicine | Schertz, TX | $9.60 | 1 |
| , MD | Sports Medicine | Edina, MN | $6.43 | 2 |
| , M.D | Family Medicine | Edina, MN | $6.43 | 2 |
| , MD | Pediatric Endocrinology | Corpus Christi, TX | $4.58 | 1 |
| , MD | Pediatric Endocrinology | Orlando, FL | $2.49 | 1 |
Ad
Manufacturing Companies
- Endo Pharmaceuticals Inc. $498,750
Product Information
- Type Drug
- Total Payments $498,750
- Total Doctors 7,113
- Transactions 23,388
About NASCOBAL
NASCOBAL is a drug associated with $498,750 in payments to 7,113 healthcare providers, recorded across 23,388 transactions in the CMS Open Payments database. The primary manufacturer is Endo Pharmaceuticals Inc..
Payment data is available from 2017 to 2024. In 2024, $1,099 was paid across 62 transactions to 54 doctors.
The most common payment nature for NASCOBAL is "Food and Beverage" ($376,402, 75.5% of total).